logo
A powerful architecture & Construction theme. Construct your website in the perfect Ratio.
Alienum phaedrum torquatos nec eu, vis detraxit periculis ex, nihil expetendis in mei. Mei an pericula
Title Image

Mucormycosis Treatment

Home / Mucormycosis Treatment

Mucormycosis In Adult Patients

Introduction:

  • Mucormycosis or Zygomycosis is a fungal disease caused by fungi of order Mucorales.
  • High risk group- Diabetes mellitus, diabetic ketoacidosis, steroid, cytotoxic drug therapy, HIV, immunosuppression, malignancy or haematological disorder including iron overload states.
  • New corona virus SARS COV 2 itself may serve as a risk factor – chronic respiratory disease, corticosteroid therapy, intubation /mechanical ventilation, deranged glucose metabolism, which may lead to secondary fungal infection.

Presenting features:

  • Facial findings

Facial swelling / Paresthesia / Discolouration of skin (necrosis)/ Infection in dangerous area of face
Facial findings 1Facial findings 2

  • Nasal findings:

Foul smelling nasal discharge/Nasal congestion/ Sinusitis/ Erythematous to violaceous to black necrotic eschar in nasal cavity

  • Intraoral findings:

Halitosis/ Intraoral pus discharge/ Ulceration & Blackening of mucosa/ Exposed palatal bone/Loosening of teeth/ Unhealed tooth socket/ Mobility of maxilla
Intraoral findings 1Intraoral findings 2

  • Orbital findings:

Vision loss/ Peri orbital cellulitis/ Chemosis/ Exophthalmos(Proptosis)/ Opthalmoplegia

Orbital findings 1

Specific points to be observed in history:

  • H/o COVID infection (Immunosuppressive drugs/ Ventilatory care, etc.)
  • Co morbid conditions: Diabetes mellitus/ Malignancy/ HIV/ Chronic kidney disease / Obesity/ Other systemic illness
  • Local factors (H/O tooth extraction or any other oral/surgical procedure/ Head injury)

Investigations:

  1. Lab parameters:
  2. Nasal endoscopic examination:
    Black necrotic eschar tissue

Nasal endoscopic

 

  • Radiographic Examination

Contrast enhanced CT scan with 3D Reconstruction findings:

  • MRI with contrast findings.

 

Biopsy:

Test

  • KOH
  • Fungal culture
  • Histopathology

Treatment:

Surgical Management:

  • Debridement of affected area as soon as possible to reduce fungal load

Medical management:

  • Mucormycosis should be treated with antifungal Injectable Amphotericin B.
  • Oral antifungal: Overlap with Injectable for 3-4 days before step down and to be continued 1 week after endoscopic biopsy is negative.
  • Liposomal amphotericin is preferred in cases having Renal complication due to Amphotericin and in case of cerebral parenchymal involvement.

1) First line antifungal therapy:
Inj Amphotericin B Deoxycholate(C-AmB): 

  • Inj Liposomal amphotericin B (LAmB):
  • Inj Amphotericin B lipid complex (ABLC) :

2) Second line- AZOLE Derivatives (Step Down or Salvage Therapy)
Step-down therapy — Posaconazole and isavuconazole are broad-spectrum azoles available in both parenteral and oral formulations
Posaconazole or isavuconazole for oral step-down therapy. Alternatively IV parenteral formulations can be used as salvage regimen in case of unresponsiveness to AmB.

  • Isavuconazole:
  • Posaconazole:

Confirm your Appointment

Our team looks forward to serve you in the best way possible. We will be glad if you fix an appointment pre-meeting with our Best ENT Doctor In Ahmedabad. You can contact us on the details given below, or just fill this short form and we’ll get right back to you!

    What People Say